401 related articles for article (PubMed ID: 24374101)
1. Can fear extinction be enhanced? A review of pharmacological and behavioral findings.
Fitzgerald PJ; Seemann JR; Maren S
Brain Res Bull; 2014 Jun; 105():46-60. PubMed ID: 24374101
[TBL] [Abstract][Full Text] [Related]
2. The use of cognitive enhancers in animal models of fear extinction.
Kaplan GB; Moore KA
Pharmacol Biochem Behav; 2011 Aug; 99(2):217-28. PubMed ID: 21256147
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA improves extinction memory retrieval after successful fear extinction.
Gerlicher AMV; Tüscher O; Kalisch R
Psychopharmacology (Berl); 2019 Dec; 236(12):3401-3412. PubMed ID: 31243481
[TBL] [Abstract][Full Text] [Related]
4. Learning and memory in conditioned fear extinction: effects of D-cycloserine.
Vervliet B
Acta Psychol (Amst); 2008 Mar; 127(3):601-13. PubMed ID: 17707326
[TBL] [Abstract][Full Text] [Related]
5. Enhancing dopaminergic signaling and histone acetylation promotes long-term rescue of deficient fear extinction.
Whittle N; Maurer V; Murphy C; Rainer J; Bindreither D; Hauschild M; Scharinger A; Oberhauser M; Keil T; Brehm C; Valovka T; Striessnig J; Singewald N
Transl Psychiatry; 2016 Dec; 6(12):e974. PubMed ID: 27922638
[TBL] [Abstract][Full Text] [Related]
6. Combination of fluoxetine and extinction treatments forms a unique synaptic protein profile that correlates with long-term fear reduction in adult mice.
Popova D; Ágústsdóttir A; Lindholm J; Mazulis U; Akamine Y; Castrén E; Karpova NN
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1162-74. PubMed ID: 24837571
[TBL] [Abstract][Full Text] [Related]
7. The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A
Neurobiol Learn Mem; 2010 Nov; 94(4):468-80. PubMed ID: 20807585
[TBL] [Abstract][Full Text] [Related]
8. Noradrenergic enhancement of reconsolidation in the amygdala impairs extinction of conditioned fear in rats--a possible mechanism for the persistence of traumatic memories in PTSD.
Dębiec J; Bush DE; LeDoux JE
Depress Anxiety; 2011 Mar; 28(3):186-93. PubMed ID: 21394851
[TBL] [Abstract][Full Text] [Related]
9. Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino TF; Fitzgerald PJ; Maren S
Neurobiol Learn Mem; 2016 Apr; 130():26-33. PubMed ID: 26808441
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.
Singewald N; Schmuckermair C; Whittle N; Holmes A; Ressler KJ
Pharmacol Ther; 2015 May; 149():150-90. PubMed ID: 25550231
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interference with metabotropic glutamate receptor subtype 7 but not subtype 5 differentially affects within- and between-session extinction of Pavlovian conditioned fear.
Toth I; Dietz M; Peterlik D; Huber SE; Fendt M; Neumann ID; Flor PJ; Slattery DA
Neuropharmacology; 2012 Mar; 62(4):1619-26. PubMed ID: 22079159
[TBL] [Abstract][Full Text] [Related]
12. Adrenergic transmission facilitates extinction of conditional fear in mice.
Cain CK; Blouin AM; Barad M
Learn Mem; 2004; 11(2):179-87. PubMed ID: 15054133
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological discrimination of extinction and reconsolidation of contextual fear memory by a potentiator of AMPA receptors.
Yamada D; Zushida K; Wada K; Sekiguchi M
Neuropsychopharmacology; 2009 Nov; 34(12):2574-84. PubMed ID: 19675539
[TBL] [Abstract][Full Text] [Related]
14. Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.
Sartori SB; Maurer V; Murphy C; Schmuckermair C; Muigg P; Neumann ID; Whittle N; Singewald N
Int J Neuropsychopharmacol; 2016 Jun; 19(6):. PubMed ID: 26625894
[TBL] [Abstract][Full Text] [Related]
15. Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity in the infralimbic prefrontal cortex and lateral amygdala.
Abumaria N; Yin B; Zhang L; Li XY; Chen T; Descalzi G; Zhao L; Ahn M; Luo L; Ran C; Zhuo M; Liu G
J Neurosci; 2011 Oct; 31(42):14871-81. PubMed ID: 22016520
[TBL] [Abstract][Full Text] [Related]
16. Effects of post-extinction l-DOPA administration on the spontaneous recovery and reinstatement of fear in a human fMRI study.
Haaker J; Lonsdorf TB; Kalisch R
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1544-55. PubMed ID: 26238968
[TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model.
Whittle N; Schmuckermair C; Gunduz Cinar O; Hauschild M; Ferraguti F; Holmes A; Singewald N
Neuropharmacology; 2013 Jan; 64(4):414-23. PubMed ID: 22722028
[TBL] [Abstract][Full Text] [Related]
18. From the neurobiology of extinction to improved clinical treatments.
Morrison FG; Ressler KJ
Depress Anxiety; 2014 Apr; 31(4):279-90. PubMed ID: 24254958
[TBL] [Abstract][Full Text] [Related]
19. Acute and long-lasting effects of oxytocin in cortico-limbic circuits: consequences for fear recall and extinction.
Triana-Del Río R; van den Burg E; Stoop R; Hegoburu C
Psychopharmacology (Berl); 2019 Jan; 236(1):339-354. PubMed ID: 30302511
[TBL] [Abstract][Full Text] [Related]
20. Hypobaric hypoxia induced fear and extinction memory impairment and effect of Ginkgo biloba in its amelioration: Behavioral, neurochemical and molecular correlates.
Kumari P; Wadhwa M; Chauhan G; Alam S; Roy K; Kumar Jha P; Kishore K; Ray K; Kumar S; Nag TC; Panjwani U
Behav Brain Res; 2020 Jun; 387():112595. PubMed ID: 32194184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
